Insider Transactions in Q3 2025 at Resmed Inc (RSMDF)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 08
2025
|
Michael J. Farrell Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
8,009
-1.68%
|
$2,226,502
$278.14 P/Share
|
|
Sep 08
2025
|
Michael J. Farrell Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,009
+1.66%
|
$808,909
$101.64 P/Share
|
|
Sep 02
2025
|
Nicole Mowad Nassar Director |
BUY
Grant, award, or other acquisition
|
Direct |
241
+50.0%
|
-
|
|
Sep 02
2025
|
Brett Sandercock Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,000
-3.31%
|
$810,000
$270.77 P/Share
|
|
Sep 02
2025
|
Brett Sandercock Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+2.16%
|
$202,000
$101.64 P/Share
|
|
Aug 18
2025
|
John Hernandez Director |
SELL
Open market or private sale
|
Direct |
2,575
-38.9%
|
$739,025
$287.1 P/Share
|
|
Aug 18
2025
|
John Hernandez Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,575
+28.0%
|
$381,100
$148.9 P/Share
|
|
Aug 15
2025
|
Justin Leong Chief Product Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,462
+16.73%
|
-
|
|
Aug 15
2025
|
Brett Sandercock Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,462
+5.8%
|
-
|
|
Aug 15
2025
|
Michael J. Farrell Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,289
+2.56%
|
-
|
|
Aug 15
2025
|
Michael J Rider Global General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
2,941
+20.47%
|
-
|
|
Aug 07
2025
|
Michael J. Farrell Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
8,009
-1.73%
|
$2,234,511
$279.48 P/Share
|
|
Aug 07
2025
|
Michael J. Farrell Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,009
+1.7%
|
$808,909
$101.64 P/Share
|
|
Aug 01
2025
|
Brett Sandercock Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,000
-3.48%
|
$843,000
$281.9 P/Share
|
|
Aug 01
2025
|
Brett Sandercock Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+2.27%
|
$202,000
$101.64 P/Share
|
|
Aug 01
2025
|
Michael J Rider Global General Counsel |
SELL
Open market or private sale
|
Direct |
50
-0.59%
|
$14,050
$281.9 P/Share
|
|
Jul 07
2025
|
Michael J. Farrell Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
8,009
-1.73%
|
$2,050,304
$256.72 P/Share
|
|
Jul 07
2025
|
Michael J. Farrell Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,009
+1.7%
|
$808,909
$101.64 P/Share
|
|
Jul 02
2025
|
Peter C Farrell Director |
SELL
Open market or private sale
|
Direct |
945
-1.37%
|
$240,975
$255.49 P/Share
|
|
Jul 01
2025
|
Brett Sandercock Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,883
-4.4%
|
$994,048
$256.99 P/Share
|
|
Jul 01
2025
|
Brett Sandercock Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,883
+1.62%
|
$291,183
$101.64 P/Share
|
|
Jul 01
2025
|
Michael J Rider Global General Counsel |
SELL
Open market or private sale
|
Direct |
66
-0.77%
|
$16,896
$256.99 P/Share
|